Abstract
Recombinant Factor VIIa as Adjunctive Therapy for Bleeding Control in Severely Injured Trauma Patients: Two Parallel Randomized, Placebo-Controlled, Double-Blind Clinical Trials
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have